Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2020 Mar 6;26(19):4232–4235. doi: 10.1002/chem.201905637

Atropisomers of meso Tetra(N‐Mesyl Pyrrol‐2‐yl) Porphyrins: Synthesis, Isolation and Characterization of All‐Pyrrolic Porphyrins

Leiming Zhu 1, Leonard Himmel 1, Jean Michél Merkes 1, Fabian Kiessling 2, Magnus Rueping 1,3, Srinivas Banala 1,2,
PMCID: PMC7187276  PMID: 31943372

Abstract

Atropisomerism has been observed in a variety of biaryl compounds and meso‐aryl substituted porphyrins. However, in porphyrins, this phenomenon had been shown only with o‐substituted 6‐membered aromatic groups at the meso‐position. We show herein that a 5‐membered heteroaromatic (N‐mesyl‐pyrrol‐2‐yl) group at the meso‐position leads to atropisomerism. In addition, we report a ‘one‐pot’ synthetic route for the synthesis of ‘all‐pyrrolic’ porphyrin (APP) with several N‐protection groups (Boc, Cbz, Ms and Ts). Among these groups, we found that only the Ms group gave four individually separable atropisomers of meso‐tetra(N‐Ms‐pyrrol‐2‐yl) porphyrin. Furthermore, the reductive removal of Cbz‐ was achieved to obtain meso‐tetra(pyrrol‐2‐yl) porphyrin. Thus, our synthetic procedure provides an easy access to a group of APPs and stable atropisomers, which is expected to expand the application of novel APP‐based materials.

Keywords: atropisomers, meso tetra(pyrrol-2-yl) porphyrin, porphyrinoids absorption spectra, porphyrins, transition-metal complexes


Stable and separable atropisomers of meso tetra(N‐mesyl pyrrol‐2‐yl) porphyrin were synthesized. Other N‐protection groups (tert‐butyloxycarbonyl (Boc), carboxybenzyl (Cbz), and Tosyl (Ts)) were explored in the ‘all‐pyrrolic porphyrins’ synthesis, but only a mixture of inseparable atropisomers were obtained.

graphic file with name CHEM-26-4232-g006.jpg

Introduction

Porphyrin chemistry has been vastly developed over the last decades, as the tetrapyrroles in hemin, chlorophyll, and vitamin B12, the ‘Pigments of Life’,1 were valuable targets for synthetic, biomimetic, and therapeutic applications. The conjugated, macrocyclic tetrapyrroles exhibit strong electronic absorption in the visible range and are highly stable, making them attractive, for biomedicine,2 catalysis,3 materials,4 and electronics.5 To fine‐tune the photophysical properties, modifications in the meso‐position with aryl, heteroaryl, and alkynyl groups (e.g. 1‐M, Figure 1) have been widely used.4c, 6 This included symmetric and mixed substituents (so called, A3B‐, A2B2‐, A2BC‐, and ABCD‐types) of porphyrins.7 In this process, by employing ortho‐substituted 6‐membered aromatic groups at meso‐positions, which hinder rotation around the plane of porphyrins, atropisomers were obtained.8 These atropisomeric porphyrins were widely studied as models for bioinorganic, and applied as ligands,9 especially attached with chiral moieties,10 in catalyst development.11

Figure 1.

Figure 1

Structures of meso‐tetra aryl (1) and (pyrrolyl) porphyrins (2, 3).

Although porphyrin synthesis is highly matured, surprisingly ‘all‐pyrrolic’ meso‐(pyrrolyl) porphyrins (APPs, for example, 2, 3) are seldom found in the literature.12 In addition, the influence of N‐substituents on pyrrol‐2‐yl porphyrin, and the possible formation of atropisomers, by such substituents are unknown. Already outside of porphyrin chemistry,13 stable atropisomers of N‐aryl pyrroles were reported,14 in which the pyrrole was substituted at the 2‐position or at the N atom with an ortho‐aryl group.15 Similarly, 3‐aryl pyrrole with an additional substituent at the 4‐position yielded separable atropisomers.16 Thus, we presumed that incorporating N‐protected pyrroles in a porphyrin at meso‐position (i.e. meso‐(pyrrol‐2‐yl) porphyrin) could yield separable atropisomers, and initiated the synthesis of APPs with different N‐protection groups.

Despite the availability of several synthetic procedures17 and a variety of meso‐aryl substituted porphyrins,18 APP is a challenging target. To date, only one synthesis of APP has been reported, using an N‐alkyl group (2‐M, Figure 1, top).12 For its preparation, N‐alkylated (Me, iPr) 2,4‐diformyl pyrrole was treated with pyrrole in the presence of acid catalysts, and six regioisomers of APP could be isolated from the mixture, but no atropisomers.12 Similarly, no atropisomers were found for mono‐19 and bis‐meso (pyrrol‐2‐yl) porphyrins,20 albeit using 1H‐pyrrole.

We are interested in exploring a suitable ‘one‐pot’ method for the synthesis of tetra(N‐protected pyrrol‐2‐yl) porphyrins. In addition, by choosing a variety of N‐protection groups for the pyrrole‐2‐aldehyde, we wished to explore the formation of atropisomers, and their isolation. Herein, we report successful procedures towards those APPs, and the isolation and characterization of stable atropisomers.

Results and Discussion

For the synthesis of APP 3, we envisaged to apply ‘one‐pot’ tetramerization procedures. Among several known methods, we chose to explore NH2OHHCl mediated condensation, as it was successfully applied to meso tetra(theinyl‐2‐yl) porphyrin synthesis.21 In addition, the broadly applicable Lindsey's method, using catalytic BF3 OEt2,18 and a recently reported reaction using p‐toluenesulfonic acid (pTSA) in hot DMF were selected.22 As in the synthesis of 2, N‐alkylated (Me, iPr) pyrrole‐2‐aldehydes (4‐Me, 4iPr) were explored in former two conditions. However, they did not yield any product, and only starting materials were observed. We assumed that the Lewis acid activated formyl group was stabilized by the electron‐rich nature of pyrrole, suppressing further reaction towards the condensation. Thus, we anticipated that removal of electron density from the pyrrole‐2‐aldehyde could enhance the tendency for the condensation reaction.

Therefore, we introduced electron‐withdrawing groups at the nitrogen of the pyrrole‐2‐aldehyde. We chose commonly used protection groups; tert‐butyloxycarbonyl (Boc, 4 a), carboxybenzyl (Cbz, 4 b), methanesulfonyl (Ms, 4 c) and tosyl (Ts, 4 d), which can be removed under acidic, neutral, and basic conditions, respectively (Scheme 1)

Scheme 1.

Scheme 1

Tetramerization of pyrrol‐2‐aldehydes and pyrrole towards 3‐M. i) Conditions in Table 1 and Table S2; ii) in DMF, 100 °C; for 3‐Zn, Zn(OAc)2 and for 3‐Ni, Ni(OAc)2. iii) THF/MeOH (4:1), 5 % Pd/C, H2 (1 atm), rt.

First the NH2OHHCl‐mediated reactions of 4 ad with pyrrole were carried out and APPs 3 ad‐2H could be obtained in 12 to 48 % yields (Table 1). Similarly, Lindsey's method using BF3 OEt2 gave us 11–50 % of APPs. Among the four N‐substituents, Cbz‐protected 4 b in Lindsey's method gave the highest yield of 3 b‐2H, 50 %, followed by NH2OHHCl with Ms‐protected 4 c giving 48 % of 3 c‐2H. When 4 d (Ts‐protected) was employed in the synthesis, 15 and 27 % of 3 d2H were isolated, respectively. Other explored conditions with 4 c and 4 d gave far lower yields of APPs (Table S2, Supporting Information).

Table 1.

Tetramerization conditions and obtained yields.

No.

(N‐R1‐Py‐CHO)

Tetramerization Catalyst

Product (3R‐2H)

Yield [%][c]

1

Boc (4 a)

NH2OHHCl[a]

3 a‐2H

12

2

Boc (4 a)

BF3 OEt2 [b]

3 a‐2H

11

4

Cbz (4 b)

NH2OHHCl[a]

3 b‐2H

10

4

Cbz (4 b)

BF3 OEt2 [b]

3 b‐2H

50

5

Ms (4 c)

NH2OHHCl[a]

3 c‐2H

48

6

Ms (4 c)

BF3 OEt2 [b]

3 c‐2H

23

7

Ts (4 d)

NH2OHHCl[a]

3 d‐2H

27

8

Ts (4 d)

BF3 OEt2 [b]

3 d‐2H

15

[a] i) Equimolar amounts of NH2OHHCl, pyrrole and 4‐R1 in chlorobenzene, 24 h, rt. ii) Nitrobenzene, 2 h, 130 °C. [b] i) 0.1 equiv. of BF3 OEt2, into equimolar amounts of pyrrole and 4‐R1 in DCM. ii) p‐Chloranil, reflux, 1 h. [c] Combined yield of all atropisomers.

To our satisfaction, the N‐sulfonyl pyrrole aldehydes (Ms, 4 c and Ts, 4 d) yielded chromatographically separable atropisomer mixtures. In particular, the Ms‐protection gave four separable atropisomers of (N‐Ms pyrrole‐2‐yl) porphyrin 3 c‐2H (Figure 3) in 48 % combined yield. With Ts‐protection only one out of four atropisomers could be separated, and the others could only be obtained as a mixture. In contrast, the N‐carbamate‐protected pyrrole (Boc, 4 a and Cbz, 4 b) gave no separable atropisomers of APP (3 a‐2H, 3 b‐2H), although their existence was proved by NMR spectroscopy.

Figure 3.

Figure 3

Atropisomers of meso (N‐mesyl‐pyrrol‐2‐yl) porphyrins 3 c‐2H.

All four atropisomeric porphyrins 3 c‐2H exhibited similar UV/Vis absorption characteristics, a Soret band at ≈425 nm and Q bands at ≈517, 554, 591 and 645 nm (Figure 2 top, Table S3, Supporting Information). By using 1H NMR, the four atropisomers (Figure 2 bottom, Figures S17—S26, Supporting Information) could be identified: the first nonpolar isomer (F1) gave a highly symmetric spectrum, a s for the CH of porphyrin at δ=8.98 ppm, hence identified as αααα‐3 c2H (Figure 3). The medium polar fraction (F2) gave two s for CH‐protons, hence the αβαβ‐isomer, the following fraction (F3) gave a highly unsymmetrical spectrum, likely corresponding to the ααββ‐isomer. The final polar fraction (F4) showed a symmetric (F1‐like) spectrum, with a broadened s CH signal of the porphyrin at δ=8.95 ppm (width=36 Hz in 600 NMR); this lead us to assign it as an αααβ‐isomer. The ratio of atropisomers, based on the isolated yields, was found to be 5.9:3.7:2.9:1 (F1:F2:F3:F4).

Figure 2.

Figure 2

Top: Normalized UV/Vis spectral overlay of 3 c‐2H atropisomer fractions and fluorescence emission spectra (inset box) for excitation at 590 nm (in CH2Cl2). Bottom: Part of 1H NMR (600 MHz, CD2Cl2) spectra of atropisomers (see the Supporting Information for full spectra, Figures S17, S19, S21, and S23).

The stability of the atropisomers was further investigated by variable temperature (VT) NMR in toluene‐d6 (Figures S27 to S30, Supporting Information). Heating the solutions up to 80 °C rendered no change in their respective signal pattern (Figures S26–S29). When the F3 was further heated to 100 °C, for 4 h, some isomerization was observed (Figures S16 and S30, Supporting Information). This confirms that the atropisomers of 3 c‐2H are highly stable and possess a high isomerization energy barrier.

In the next step, to prove the inherent metal‐complexation ability of APP, N‐sulfonyl (pyrrolyl‐2‐yl) porphyrins (3 c‐2H, 3 d‐2H) were metallated with ZnII and NiII acetate in hot DMF. The resulting metallo‐APPs showed the characteristic Q band peaks at 554 nm with a shoulder at 590 nm for 3 c‐Zn, and at 534 nm with a shoulder at 567 nm for 3 c‐Ni (Figure 4).

Figure 4.

Figure 4

UV/Vis absorption of metallated meso (N‐sulfonyl 2‐pyrrolyl) porphyrin (inset Q bands).

With metallated 3 c‐Zn, 3 c‐Ni and 3 d‐Zn, 3 d‐Ni in hand, deprotection was carried out using NaOH in THF/MeOH (4:1) and CH2Cl2/MeOH (5:1). The reactions were stirred at 20 °C under protection from light for up to 72 h; however, no reaction was observed. By refluxing the same mixture, a greenish product was obtained. 1H NMR (in CD2Cl2) of the dry mixtures indicated the formation of a polymeric material. Even under exclusion of oxygen the same results were obtained.

To further explore the feasibility of deprotection of APPs under neutral conditions, N‐Cbz removal in 3 b‐2H (using a mixture of inseparable atropisomers) was studied using 5 % Pd/C and H2 (1 atm.) in THF/MeOH. From this we could identify highly symmetric meso‐tetra(pyrrol‐2‐yl) porphyrin (3 e‐2H), albeit isolated in protonated form (Figure S36, Supporting Information). However, directly after removing the solvents, no protonation was observed in the reaction mixture as confirmed by 1H NMR (CD3OD) (Figure S35, Supporting Information). Therefore, the protonation might have occurred during the purification using CH2Cl2/MeOH. Further spontaneous polymerization of unprotonated electron‐rich 3 e‐2H was evaluated in an oxygen environment by 1H NMR (in CD3OD). The 3 e‐2H was found to be stable even after storing the solution for 90 days at room temperature; however, the polymerization was observed when it was heated. Therefore, selective polymerization to make size‐specific polymeric APP is possible using tetra(pyrrol‐2‐yl) porphyrin, which is currently being explored.

Conclusions

Herein, we report generally applicable synthetic methods for the preparation of different meso tetra(N‐protected pyrrol‐2‐yl) porphyrins (APPs). It was found that an electron‐withdrawing group at the N‐position in pyrrol‐2‐aldehyde was essential for tetramerization to yield APPs. Among the explored conditions, the Lindsey's method with N‐Cbz pyrrol‐2‐aldehyde gave 50 %, and the NH2OHHCl mediated condensation with N‐Ms pyrrol‐2‐aldehyde gave 48 % of respective APPs. In addition, the N‐Ms pyrrol‐2‐aldehyde gave stable and separable four atropisomers of tetra(N‐Ms pyrrol‐2‐yl) porphyrin. These hitherto inaccessible all‐pyrrolic porphyrins were metallated with transition metals. The metallo APPs possess similar photophysical characteristics to meso tetra aryl porphyrins. The high reactivity of the meso (pyrrol‐2‐yl) group in porphyrin, upon removal of protection group, is a useful feature for the preparation of pyrrole–pyrrole‐bridged porphyrin sheets and nanoparticles, which is currently under investigation.

Conflict of interest

The authors declare no conflict of interest.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary

Acknowledgements

Financial support by the Excellence Initiative of the German federal and state governments through the I3TM Seed Fund Program is acknowledged. The authors thank Prof. M. Albrecht for generous use of spectrometers.

L. Zhu, L. Himmel, J. M. Merkes, F. Kiessling, M. Rueping, S. Banala, Chem. Eur. J. 2020, 26, 4232.

Dedicated to Professor emer. Dr. Bernhard Kräutler (University of Innsbruck)

References

  • 1. 
  • 1a. Battersby A. R., Nat. Prod. Rep. 2000, 17, 507–526; [DOI] [PubMed] [Google Scholar]
  • 1b. Kräutler B., Jaun B., in Concepts and Models in Bioinorganic Chemistry (Eds.: H.-B. Kraatz, N. Metzler-Nolte), Wiley-VCH, Weinheim, 2006, pp. 177–212. [Google Scholar]
  • 2. Josefsen L. B., Boyle R. W., Theranostics 2012, 2, 916–966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Barona-Castaño J. C., Carmona-Vargas C. C., Brocksom T. J., De Oliveira K. T., Molecules 2016, 21, 310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. 
  • 4a. Paolesse R., Nardis S., Monti D., Stefanelli M., Di Natale C., Chem. Rev. 2017, 117, 2517–2583; [DOI] [PubMed] [Google Scholar]
  • 4b. Auwärter W., Ecija D., Klappenberger F., Barth J. V., Nat. Chem. 2015, 7, 105–120; [DOI] [PubMed] [Google Scholar]
  • 4c. Longevial J.-F., Clément S., Wytko J. A., Ruppert R., Weiss J., Richeter S., Chem. Eur. J. 2018, 24, 15442–15460. [DOI] [PubMed] [Google Scholar]
  • 5. Li L.-L., Diau E. W.-G., Chem. Soc. Rev. 2013, 42, 291–304. [DOI] [PubMed] [Google Scholar]
  • 6. 
  • 6a. Lindsey J. S., in The Porphyrin Handbook, Vol. 1 (Eds.: K. M. Kadish, K. M. Smith, R. Guilard), Academic Press, San Diego, 2000, pp. 45–118; [Google Scholar]
  • 6b. Song J., Aratani N., Shinokubo H., Osuka A., Chem. Eur. J. 2010, 16, 13320–13324. [DOI] [PubMed] [Google Scholar]
  • 7. 
  • 7a. Senge M. O., Chem. Commun. 2011, 47, 1943–1960; [DOI] [PubMed] [Google Scholar]
  • 7b. Hiroto S., Miyake Y., Shinokubo H., Chem. Rev. 2017, 117, 2910–3043. [DOI] [PubMed] [Google Scholar]
  • 8. 
  • 8a. Collman J. P., Gagne R. R., Reed C., Halbert T. R., Lang G., Robinson W. T., J. Am. Chem. Soc. 1975, 97, 1427–1439; [DOI] [PubMed] [Google Scholar]
  • 8b. Gottwald L. K., Ullman E. F., Tetrahedron Lett. 1969, 10, 3071–3074; [Google Scholar]
  • 8c. Lindsey J., J. Org. Chem. 1980, 45, 5215. [Google Scholar]
  • 9. Paul D., Melin F., Hirtz C., Wytko J., Ochsenbein P., Bonin M., Schenk K., Maltese P., Weiss J., Inorg. Chem. 2003, 42, 3779–3787. [DOI] [PubMed] [Google Scholar]
  • 10. 
  • 10a. Mansuy D., Battioni P., Renaud J. P., Guerin P., J. Chem. Soc. Chem. Commun. 1985, 155–156; [Google Scholar]
  • 10b. Boitrel B., Baveux-Chambenoît V., New J. Chem. 2003, 27, 942–947. [Google Scholar]
  • 11. Collman J. P., Zhang X., Lee V. J., Uffelman E. S., Brauman J. I., Science 1993, 261, 1404–1411. [DOI] [PubMed] [Google Scholar]
  • 12. Furuta H., Maeda H., Furuta T., Osuka A., Org. Lett. 2000, 2, 187–189. [DOI] [PubMed] [Google Scholar]
  • 13. Laha J. K., Bhimpuria R. A., Prajapati D. V., Dayal N., Sharma S., Chem. Commun. 2016, 52, 4329–4332. [DOI] [PubMed] [Google Scholar]
  • 14. Zhang L., Zhang J., Ma J., Cheng D.-J., Tan B., J. Am. Chem. Soc. 2017, 139, 1714–1717. [DOI] [PubMed] [Google Scholar]
  • 15. 
  • 15a. Wang Y.-B., Wu Q.-H., Zhou Z.-P., Xiang S.-H., Cui Y., Yu P., Tan B., Angew. Chem. Int. Ed. 2019, 58, 13443–13447; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2019, 131, 13577–13581; [Google Scholar]
  • 15b. Zhang L., Xiang S.-H., Wang J., Xiao J., Wang J.-Q., Tan B., Nat. Commun. 2019, 10, 566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. 
  • 16a. He X.-L., Zhao H.-R., Song X., Jiang B., Du W., Chen Y.-C., ACS Catal. 2019, 9, 4374–4381; [Google Scholar]
  • 16b. Zheng S.-C., Wang Q., Zhu J., Angew. Chem. Int. Ed. 2019, 58, 9215–9219; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2019, 131, 9313–9317. [Google Scholar]
  • 17. Adler A. D., Longo F. R., Finarelli J. D., Goldmacher J., Assour J., Korsakoff L., J. Org. Chem. 1967, 32, 476. [Google Scholar]
  • 18. 
  • 18a. Wagner R. W., Lindsey J. S., J. Org. Chem. 1989, 54, 828–836; [Google Scholar]
  • 18b. Lindsey J. S., Schreiman I. C., Hsu H. C., Kearney P. C., Marguerettaz A. M., J. Org. Chem. 1987, 52, 827–836. [Google Scholar]
  • 19. 
  • 19a. Saltsman I., Gross Z., Tetrahedron Lett. 2008, 49, 247–249; [Google Scholar]
  • 19b. Schmidt I., Jiao J., Thamyongkit P., Sharada D. S., Bocian D. F., Lindsey J. S., J. Org. Chem. 2006, 71, 3033–3050. [DOI] [PubMed] [Google Scholar]
  • 20. Xu L., Wen B., Kim G., Kim T., Cheng F., Zhou M., Xu L., Tanaka T., Yin B., Osuka A., Kim D., Song J., Angew. Chem. Int. Ed. 2017, 56, 12322–12326; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2017, 129, 12490–12494. [Google Scholar]
  • 21. Betoni Momo P., Pavani C., Baptista M. S., Brocksom T. J., Thiago de Oliveira K., Eur. J. Org. Chem. 2014, 4536–4547. [Google Scholar]
  • 22. Fadda A. A., El-Mekawy R. E., El-Shafei A. I., Freema H., Arch. Pharm. 2013, 346, 53–61. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary


Articles from Chemistry (Weinheim an Der Bergstrasse, Germany) are provided here courtesy of Wiley

RESOURCES